Robert M Dean (Robert Dean)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Peritoneal Dialysis

Body Composition

Chronic Lymphocytic Leukemia

Top Venues

Leukemia & lymphoma

Bone marrow transplantation

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

Brian T Hill, Yanwen Chen, Deepa Jagadeesh, Robert M Dean, Omer Koc, Kirsten Boughan, Brenda W Cooper, Brad Pohlman, Paolo F Caimi, Mitchell Reed Smith
Lenalidomide, rituximab (R 2 ), and ixazomib for frontline treatment of high risk follicular and indolent non-Hodgkin lymphoma. Leukemia & lymphoma 65 (6) (2024)
Brian T Hill, Yanwen Chen, Deepa Jagadeesh, Robert M Dean, Omer Koc, Kirsten Boughan, Brenda W Cooper, Brad Pohlman, Paolo F Caimi, Mitchell Reed Smith
Lenalidomide, rituximab (R 2 ), and ixazomib for frontline treatment of high risk follicular and indolent non-Hodgkin lymphoma. Leukemia & lymphoma 65 (6) (2024)
Brian T Hill, Yanwen Chen, Deepa Jagadeesh, Robert M Dean, Omer Koc, Kirsten Boughan, Brenda W Cooper, Brad Pohlman, Paolo F Caimi, Mitchell Reed Smith
Lenalidomide, rituximab (R 2 ), and ixazomib for frontline treatment of high risk follicular and indolent non-Hodgkin lymphoma. Leukemia & lymphoma (2024)
Brian T Hill, Yanwen Chen, Deepa Jagadeesh, Robert M Dean, Omer Koc, Kirsten Boughan, Brenda W Cooper, Brad Pohlman, Paolo F Caimi, Mitchell Reed Smith
Lenalidomide, rituximab (R 2 ), and ixazomib for frontline treatment of high risk follicular and indolent non-Hodgkin lymphoma. Leukemia & lymphoma 65 (6) (2024)
Agrima Mian, Wei Wei, Betty K Hamilton, Allison M Winter, Jack Khouri, Brad Pohlman, Aaron T Gerds, Deepa Jagadeesh, Faiz Anwar, Matt Kalaycio, Robert M Dean, Ronald Sobecks, Paolo F Caimi, Brian T Hill, Navneet S Majhail
Resource utilization in patients with large B-cell lymphoma receiving tisagenlecleucel and axicabtagene ciloleucel. Bone marrow transplantation (2023)
Betty K Hamilton, Lisa A Rybicki, Hong Z Li, Taylor Lucas, Donna Corrigan, Matt E Kalaycio, Ronald M Sobecks, Rabi Hanna, Seth J Rotz, Robert M Dean, Aaron T Gerds, Deepa Jagadeesh, Claudio G Brunstein, Craig S Sauter, Edward A Copelan, Navneet S Majhail
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-vs-host disease prevention. Blood advances (2023)
Gabriel F P Aleixo, Wei Wei, Po-Hao Chen, Namita S Gandhi, Faiz Anwar, Robert M Dean, Betty K Hamilton, Brian T Hill, Deepa Jagadeesh, Jack Khouri, Brad Pohlman, Ronald Sobecks, Allison Winter, Paolo Caimi, Navneet S Majhail
The association of body composition and outcomes following autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma. Bone marrow transplantation (2023)
Agrima Mian, Wei Wei, Betty K Hamilton, Allison M Winter, Jack Khouri, Brad Pohlman, Aaron T Gerds, Deepa Jagadeesh, Faiz Anwar, Matt Kalaycio, Robert M Dean, Ronald Sobecks, Paolo F Caimi, Brian T Hill, Navneet S Majhail
Resource utilization in patients with large B-cell lymphoma receiving tisagenlecleucel and axicabtagene ciloleucel. Bone marrow transplantation (2023)
Kelly J Gaffney, Theresa A Urban, Mariana Lucena, Faiz Anwer, Robert M Dean, Aaron T Gerds, Betty K Hamilton, Deepa Jagadeesh, Matt E Kalaycio, Jack Khouri, Brad Pohlman, Ronald Sobecks, Allison Winter, Lisa Rybicki, Navneet S Majhail, Brian T Hill
Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Pranay S Hegde, Lisa Rybicki, Sheila Serafino, Laura Bernhard, Donna Corrigan, Faiz Anwar, Matt Kalaycio, Ronald M Sobecks, Deepa Jagadeesh, Brian T Hill, Robert M Dean, Jack Khouri, Allison M Winter, Brad Pohlman, Navneet S Majhail, Betty K Hamilton
Evaluation of pre-transplant risk assessments in allogeneic hematopoietic cell transplant. Bone marrow transplantation 57 (6) (2022)